MYC and adenocarcinoma: Using a rapidly and reversibly switchable genetic system (Murphy et al., 2008), we define the causal sequence of events by which Myc drives conversion of indolent adenomas to aggressive, inflammatory, and immune-suppressed adenocarcinomas and by which subsequent Myc de-activation triggers tumor regression.